Bagilin® is a long-acting insulin glargine, designed for the treatment of type 1 and type 2 diabetes mellitus.
Each box contains 5 pre-filled SoloStar® pens, each with 3 ml of injectable solution (100 IU/mL). Its formula provides stable blood glucose control for 24 hours, reducing the need for multiple daily injections.
Each ml of solution contains 3.64 mg of insulin glargine, equivalent to 100 IU, in 3 ml glass cartridges within a disposable subcutaneous injection device.
Ideal for patients who require a reliable, safe, and practical basal insulin regimen.
🔹 Benefits of Bagilin®
-
Long-acting action: Provides stable basal glucose control for 24 hours, reducing spikes and drops.
-
Fewer injections: As a slow-release insulin, generally only one daily injection is needed.
-
Pre-filled pens: Ready to use, avoiding dosing errors and the need to prepare vials.
-
Higher precision: The SoloStar® device allows accurate dosing for each patient.
-
Practical use: Ergonomic, discreet design, easy to use anytime, anywhere.
-
Safety: Each pen is disposable, minimizing contamination or improper reuse risks.
-
Proven stability: Insulin glargine is widely validated in clinical studies for efficacy and safety.
-
Lower risk of nighttime hypoglycemia: Its action profile helps reduce low sugar episodes overnight.
-
Compatibility: Suitable for both type 1 and type 2 diabetes, adaptable to various treatment regimens.
-
Accessibility: Bagilin® is a more affordable alternative compared to other insulin brands, without sacrificing quality.
